For more information on Adherence 2018, visit their website by clicking here.
This annual series of conferences is dedicated to the presentation and discussion of HIV treatment and biomedical prevention adherence research, and current behavioral and clinical perspectives in practicum, within the context of achieving optimized HIV care and prevention continua. The theme of this year’s conference is Action to Impact.
This year’s conference program will feature a keynote address, memorial lecture, and memorial colloquium, as well as networking breakfasts (2), plenary addresses (4), panel discussions (4), oral abstract sessions (4), a late-breaker abstract session, and a poster session. Three pre-conference sessions are scheduled for the morning of June 8, 2018. Click here to view the program.
Adherence 2018 is sponsored by the International Association of Providers of AIDS Care (IAPAC). The conference’s Co-Chairs are Catherine Orrell, MBChB, MSc, MMed (Desmond Tutu HIV Center, Cape Town, South Africa) and Robert Remien, PhD (Columbia University, New York, NY, USA).
The conference Track Chairs are Thomas P. Giordano, MD, MPH (Baylor College of Medicine, Houston, TX, USA); Jean-Jacques Parienti, MD, PhD (Centre Hospitalier Universitaire de Caen, Caen, France); and Jane M. Simoni, PhD (University of Washington, Seattle, WA, USA).
IAPAC is honored to announce that Salim Abdool Karim, MBBCh, PhD, a clinical epidemiologist and infectious diseases specialist, will deliver the Keynote Address at Adherence 2018.
Other confirmed Adherence 2018 faculty (as of January 25, 2018) include:
• K. Rivet Amico, PhD (University of Michigan, Ann Arbor, MI, USA)
• Peter Anderson, PharmD (University of Colorado, Denver, CO, USA)
• Millicent Atujuna, PhD (Desmond Tutu HIV Centre, Cape Town, South Africa)
• Amb. Deborah L. Birx, MD (Office of the Global AIDS Coordinator, Washington, DC, USA)
• Sara Browne, MD (University of California, San Diego, CA, USA)
• Erika Castellanos (GATE, Belize City, Belize)
• José Castillo-Mancilla, MD (University of Colorado, Denver, CO, USA)
• Monica Gandhi, MD, MPH (University of California, San Francisco, CA, USA)
• Roy Gulick, MD, MPH (Cornell University, Ithaca, NY, USA)
• Jessica Haberer, MD (Massachusetts General Hospital, Boston, MA, USA)
• Lisa Hightow-Weidman, MD (University of North Carolina, Chapel Hill, NC, USA)
• Ingrid Katz, MD (Brigham and Women’s Hospital, Boston, MA, USA)
• Helen Koenig, MD (University of Pennsylvania, Philadelphia, PA, USA)
• Sebastian Linnemayr, PhD (RAND Corporation, Santa Monica, CA, USA)
• Kenneth Mayer, MD (Fenway Health, Boston, MA, USA)
• Lawrence Mbuagbaw, MD, PhD, MPH (McMaster Univeristy, Hamilton, ON, Canada)
• Michael Mugavero, MD, MHSc (University of Alabama at Birmingham, AL, USA)
• Andrew Mujugira, MD, MPH (Makerere University, Kampala, Uganda)
• Mark Nelson, MBBS (Chelsea & Westminster Hospital, London, England)
• Aadia Rana, MD (University of Alabama at Birmingham, AL, USA)
• Bruce Richman, JD (Prevention Access Campaign, Brooklyn, NY, USA)
• Kenly Sikwese (African Community Advisory Board, Lusaka, Zambia)
• Laurel Sprague, PhD (GNP+, Amsterdam, The Netherlands)
• Lucy Wanjiku Njenga (Positive Young Women Voices, Nairobi, Kenya)
• Ira Wilson, MD, MSc (Brown University, Providence, RI, USA)
KEY DATES TO REMEMBER
Early Registration Deadline – March 23, 2018
Standard Registration Deadline – May 4, 2018
Registration Cancellation Deadline (with $100 penalty) – May 18, 2018
Abstract Submission Deadline – February 23, 2018
Abstract Disposition Announcements – March 30, 2018
Late-Breaker Abstract Submissions – April 2-9, 2018
Late-Breaker Abstract Disposition Announcements – April 20, 2018
Early Registration Rate (for presenting authors only) – May 11, 2018
Deadline to Withdraw Abstract/Change Presenting Author – May 11, 2018
Discounted Room Block Reservation Deadline – May 7, 2018
In keeping with the Adherence 2018 theme, Action to Impact, the conference organizers welcome abstracts on the scaling up of interventions and programs (“action”) which have had marked effects (“impact”) on treatment and biomedical prevention adherence and achieving optimized continuum of HIV care and prevention outcomes.
Abstract submissions are encouraged in a wide variety of specific domains, including:
Antiretroviral therapy medication and medication adherence
Linkage, retention, and re-engagement in HIV care
Adherence and engagement in biomedical HIV prevention strategies
Engagement in multiple areas in the continuum of HIV care
Within these areas we encourage coverage of:
Advances in basic science (pharmacodynamics, formulations, long-acting agents)
Novel/innovative monitoring and measurement strategies
Longitudinal or observational data
Innovations in modeling and bio-psychosocial theory